Eco R1 Capital, LLC Tempest Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.3 - $1.39 $57,730 - $267,483	-192,434 Reduced 17.13%	931,000 $279,000
Q2 2023 Aug 14, 2023	BUY	$1.12 - $3.76 $103,225 - $346,544	92,166 Added 8.94%	1,123,434 $1.43 Million
Q2 2022 Aug 15, 2022	BUY	$2.08 - $4.15 $2.15 Million - $4.28 Million	1,031,268 New	1,031,268 $2.22 Million

2.46M

44.9K

109K

Ticker TPST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,418,900
Market Cap $9.59M
Description
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.